Chris Cooley
Stock Analyst at Stephens & Co.
(1.94)
# 1,660
Out of 4,415 analysts
39
Total ratings
70%
Success rate
45.3%
Average return
Main Sectors:
Top Industries:
16 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCEL Vericel | Maintains: Overweight | $39 → $42 | $47.83 | -12.19% | 2 | May 11, 2023 | |
| ALGN Align Technology | Maintains: Overweight | $500 → $375 | $287.87 | +30.27% | 6 | Jul 28, 2022 | |
| COO The Cooper Companies | Maintains: Overweight | $125 → $115 | $90.64 | +26.88% | 7 | Jun 3, 2022 | |
| ALC Alcon | Upgrades: Overweight | $86 → $92 | $79.57 | +15.62% | 4 | May 12, 2022 | |
| PLSE Pulse Biosciences | Maintains: Overweight | $14 → $12 | $8.05 | +49.07% | 2 | Apr 1, 2022 | |
| ANIK Anika Therapeutics | Downgrades: Equal-Weight | n/a | $27.59 | - | 2 | Mar 9, 2022 | |
| ESTA Establishment Labs Holdings | Maintains: Overweight | n/a | $52.83 | - | 2 | Nov 10, 2021 | |
| STE STERIS | Maintains: Overweight | n/a | $207.82 | - | 3 | Nov 4, 2021 | |
| GKOS Glaukos | Upgrades: Overweight | n/a | $105.03 | - | 3 | Nov 3, 2021 | |
| AVNS Avanos Medical | Downgrades: Equal-Weight | n/a | $19.71 | - | 1 | Aug 4, 2021 | |
| TFX Teleflex | Maintains: Overweight | n/a | $198.73 | - | 1 | Mar 23, 2020 | |
| STAA STAAR Surgical Company | Maintains: Overweight | n/a | $45.51 | - | 1 | Mar 23, 2020 | |
| DXCM DexCom | Maintains: Overweight | n/a | $128.37 | - | 2 | Mar 23, 2020 | |
| CUTR Cutera | Maintains: Overweight | n/a | $2.53 | - | 1 | Mar 23, 2020 | |
| BSX Boston Scientific | Maintains: Overweight | n/a | $72.85 | - | 1 | Mar 23, 2020 | |
| PODD Insulet | Maintains: Equal-Weight | n/a | $174.43 | - | 1 | Feb 22, 2018 |
Vericel
May 11, 2023
Maintains: Overweight
Price Target: $39 → $42
Current: $47.83
Upside: -12.19%
Align Technology
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $375
Current: $287.87
Upside: +30.27%
The Cooper Companies
Jun 3, 2022
Maintains: Overweight
Price Target: $125 → $115
Current: $90.64
Upside: +26.88%
Alcon
May 12, 2022
Upgrades: Overweight
Price Target: $86 → $92
Current: $79.57
Upside: +15.62%
Pulse Biosciences
Apr 1, 2022
Maintains: Overweight
Price Target: $14 → $12
Current: $8.05
Upside: +49.07%
Anika Therapeutics
Mar 9, 2022
Downgrades: Equal-Weight
Price Target: n/a
Current: $27.59
Upside: -
Establishment Labs Holdings
Nov 10, 2021
Maintains: Overweight
Price Target: n/a
Current: $52.83
Upside: -
STERIS
Nov 4, 2021
Maintains: Overweight
Price Target: n/a
Current: $207.82
Upside: -
Glaukos
Nov 3, 2021
Upgrades: Overweight
Price Target: n/a
Current: $105.03
Upside: -
Avanos Medical
Aug 4, 2021
Downgrades: Equal-Weight
Price Target: n/a
Current: $19.71
Upside: -
Teleflex
Mar 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $198.73
Upside: -
STAAR Surgical Company
Mar 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $45.51
Upside: -
DexCom
Mar 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $128.37
Upside: -
Cutera
Mar 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $2.53
Upside: -
Boston Scientific
Mar 23, 2020
Maintains: Overweight
Price Target: n/a
Current: $72.85
Upside: -
Insulet
Feb 22, 2018
Maintains: Equal-Weight
Price Target: n/a
Current: $174.43
Upside: -